Stay updated on TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T01:03:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T21:16:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T16:16:47.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T03:39:42.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the study protocol (v2.15.0) and includes the name of a collaborator, Trillium Therapeutics Inc., while removing detailed descriptions of the study's objectives and inclusion/exclusion criteria for participants with multiple myeloma.
    Difference
    42%
    Check dated 2025-04-16T20:21:41.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 17, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.4%
    Check dated 2025-04-09T13:19:51.000Z thumbnail image

Stay in the know with updates to TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TTI-622 and Daratumumab Combo in Multiple Myeloma Clinical Trial page.